Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

被引：3
|
作者：
Wang, Norman C. [1 ]
Piccini, Jonathan P. [2 ]
Gheorghiade, Mihai [3 ]
机构：
[1] Univ Pittsburgh, Cardiovasc Inst, Med Ctr, Pittsburgh, PA 15213 USA
[2] Duke Clin Res Ctr, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
HEART FAILURE REVIEWS | 2011年 / 16卷 / 05期
关键词：
Implantable cardioverter-defibrillator; Heart failure; Hospitalization; Mortality; VENTRICULAR EJECTION FRACTION; MYOCARDIAL-INFARCTION; SURVIVAL; HOSPITALIZATION; DEATH;
D O I：
10.1007/s10741-011-9243-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.
引用
收藏
页码：477 / 480
页数：4
相关论文
共 50 条
  • [1] Prophylactic implantable cardioverter-defibrillator in the very elderly
    Zakine, Cyril
    Garcia, Rodrigue
    Narayanan, Kumar
    Gandjbakhch, Estelle
    Algalarrondo, Vincent
    Lellouche, Nicolas
    Perier, Marie-Cecile
    Fauchier, Laurent
    Gras, Daniel
    Bordachar, Pierre
    Piot, Olivier
    Babuty, Dominique
    Sadoul, Nicolas
    Defaye, Pascal
    Deharo, Jean-Claude
    Klug, Didier
    Leclercq, Christophe
    Extramiana, Fabrice
    Boveda, Serge
    Marijon, Eloi
    EUROPACE, 2019, 21 (07): : 1063 - 1069
  • [2] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Al-Majed, Nawaf S.
    Ezekowitz, Justin A.
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 299 - 307
  • [3] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    Current Cardiology Reports, 2012, 14 : 299 - 307
  • [4] Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure Registry
    Cho, Youngjin
    Cho, Sang-Yeong
    Oh, Il-Young
    Lee, Ji Hyun
    Park, Jin Joo
    Lee, Hae-Young
    Kim, Kye Hun
    Yoo, Byung-Su
    Kang, Seok-Min
    Baek, Sang Hong
    Jeon, Eun-Seok
    Kim, Jae-Joong
    Cho, Myeong-Chan
    Chae, Shung Chull
    Oh, Byung-Hee
    Choi, Dong-Ju
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (46) : e397
  • [5] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [6] Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population
    Ahmadi-Kashani, Mastaneh
    Kessler, David J.
    Day, John
    Bunch, T. Jared
    Stolen, Kira Q.
    Brown, Scott
    Sbaity, Salam
    Olshansky, Brian
    CIRCULATION, 2009, 120 (21) : 2040 - 2045
  • [7] Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter-Defibrillator Therapies
    Aktas, Mehmet K.
    Kim, David D.
    McNitt, Scott
    Huang, David T.
    Rosero, Spencer Z.
    Hall, Burr W.
    Zareba, Wojciech
    Daubert, James P.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (12): : 1501 - 1508
  • [8] Implantable Cardioverter-Defibrillator Therapy in the Contemporary Era of Heart Failure Therapeutics COMMENT
    Chatterjee, Neal A.
    Levy, Wayne C.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2022, 8 (08) : 1031 - 1033
  • [9] Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
    Levy, Wayne C.
    Lee, Kerry L.
    Hellkamp, Anne S.
    Poole, Jeanne E.
    Mozaffarian, Dariush
    Linker, David T.
    Maggioni, Aldo P.
    Anand, Inder
    Poole-Wilson, Philip A.
    Fishbein, Daniel P.
    Johnson, George
    Anderson, Jill
    Mark, Daniel B.
    Bardy, Gust H.
    CIRCULATION, 2009, 120 (10) : 835 - 842
  • [10] Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction
    Mollema, Sjoerd A.
    Klein, Patrick
    Heersche, Jogien
    Schalij, Martin J.
    Van der Wall, Ernst E.
    Versteegh, Michel I. M.
    Klautz, Robert J. M.
    Van Erven, Lieselot
    Bax, Jeroen J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (07): : 913 - 917
12345